Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All XWELL, Inc. filings on SEC EDGAR ↗
XWELL stockholders approved the sale of the company's equity interests in XpresSpa Holdings, LLC and XpresTest, Inc. to Express Wellness Group, LLC. The approval was obtained at a special meeting held on October 28, 2026, where shareholders also approved an increase in the number of shares reserved for the company's 2020 equity incentive plan.
XWELL, Inc. received a deficiency notice from Nasdaq on October 7, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, or until April 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. XWELL is monitoring the situation and considering options, including a potential reverse stock split, to address the deficiency.